CELLESTIS LIMITED – Trademark Portfolio

Entity Type: 03

CELLESTIS LIMITED holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include QFM, QUANTIFERON, and QUANTIFERON MONITOR. The owner is based in Chadstone, Victoria.

1341 Dandenong Road

Office Tower 2, Chadstone Centre

Chadstone, Victoria 3148 , AU

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CELLESTIS LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (5 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does CELLESTIS LIMITED have?

CELLESTIS LIMITED has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does CELLESTIS LIMITED file in?

CELLESTIS LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are CELLESTIS LIMITED's most well-known trademarks?

CELLESTIS LIMITED's registered trademark portfolio includes well-known marks such as QFM, QUANTIFERON, and QUANTIFERON MONITOR. These are among 3 currently registered trademarks in the portfolio.

What is CELLESTIS LIMITED's trademark registration success rate?

CELLESTIS LIMITED has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.